Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme

Liu,Qingyang; Zhang,Chuanbao; Ma,Guofo; Zhang,Quangeng

doi:10.3892/ol.2013.1736

Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme

Authors:
- Qingyang Liu
- Chuanbao Zhang
- Guofo Ma
- Quangeng Zhang
View Affiliations

Affiliations: Department of Immunology, Institute of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China, Department of Neurosurgery, Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China
Published online on: December 6, 2013 https://doi.org/10.3892/ol.2013.1736
Pages: 427-432

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Esophagin, also known as small proline‑rich protein 3 (SPRR3), has been demonstrated to be important in the initiation and progression of numerous types of tumor, including colorectal and breast cancer. However, studies concerning the biological functions of SPRR3 in glioblastoma multiforme (GBM) are limited. Therefore, we aimed to identify the functions and molecular mechanisms underlying the role of SPRR3 in GBM. Hypomethylation of SPRR3 was observed and associated with a poor clinical outcome in GBM patients compared with healthy individuals by using gene methylation profiling. The present study was performed to investigate the expression status and effects of SPRR3 in GBM. The U251 cell line was used in the functional analyses. Cell growth was examined by MTT and colony formation assay. Cell invasion was measured using the Transwell invasion assay. The expression of SPRR3 in tissue samples was examined by immunohistochemistry. The results revealed that the overexpression of SPRR3 accelerates U251 cell proliferation and invasion. It was also observed that SPRR3 was markedly upregulated in 72.7% of GBM samples (24/33) compared with the normal tissue. These results suggest that an increased expression of SPRR3 is involved in tumorigenesis.

View Figures

View References

1	Parsons DW, Jones S, Zhang X, et al: An integrated genomic analysis of human glioblastoma multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
2	Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
3	Karpf AR and Matsui S: Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res. 65:8635–8639. 2005. View Article : Google Scholar
4	Bello MJ and Rey JA: The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas. Cancer Genet Cytogenet. 164:172–173. 2006. View Article : Google Scholar : PubMed/NCBI
5	Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P and Backendorf C: Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics. 16:630–637. 1993. View Article : Google Scholar
6	Steinert PM, Candi E, Kartasova T and Marekov L: Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. J Struct Biol. 122:76–85. 1998. View Article : Google Scholar
7	Zhang Y, Feng YB, Shen XM, et al: Exogenous expression of Esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis. Int J Cancer. 122:260–266. 2008. View Article : Google Scholar : PubMed/NCBI
8	Tesfaigzi J, Th’ng J, Hotchkiss JA, Harkema JR and Wright PS: A small proline-rich protein, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelia. Am J Respir Cell Mol Biol. 14:478–486. 1996. View Article : Google Scholar
9	Fischer DF, Sark MW, Lehtola MM, Gibbs S, van de Putte P and Backendorf C: Structure and evolution of the human SPRR3 gene: implications for function and regulation. Genomics. 55:88–99. 1999. View Article : Google Scholar : PubMed/NCBI
10	Cabral A, Sayin A, de Winter S, Fischer DF, Pavel S and Backendorf C: SPRR4, a novel cornified envelope precursor: UV-dependent epidermal expression and selective incorporation into fragile envelopes. J Cell Sci. 114:3837–3843. 2001.
11	Abraham JM, Wang S, Suzuki H, et al: Esophagin cDNA cloning and characterization: a tissue-specific member of the small proline-rich protein family that is not expressed in esophageal tumors. Cell Growth Differ. 7:855–860. 1996.
12	Chen BS, Wang MR, Cai Y, et al: Decreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis. 21:2147–2150. 2000. View Article : Google Scholar : PubMed/NCBI
13	Cho DH, Jo YK, Roh SA, et al: Upregulation of SPRR3 promotes colorectal tumorigenesis. Mol Med. 16:271–277. 2010.PubMed/NCBI
14	Kim JC, Yu JH, Cho YK, et al: Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer. Breast Cancer Res Treat. 133:909–916. 2012. View Article : Google Scholar : PubMed/NCBI
15	Hill VK, Ricketts C, Bieche I, et al: Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 71:2988–2999. 2011. View Article : Google Scholar : PubMed/NCBI
16	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
17	Nagarajan RP and Costello JF: Epigenetic mechanisms in glioblastoma multiforme. Semin Cancer Biol. 19:188–197. 2009. View Article : Google Scholar : PubMed/NCBI
18	Fanelli M, Caprodossi S, Ricci-Vitiani L, et al: Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene. 27:358–365. 2008. View Article : Google Scholar
19	Kim TY, Zhong S, Fields CR, Kim JH and Robertson KD: Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res. 66:7490–7501. 2006. View Article : Google Scholar : PubMed/NCBI
20	Foltz G, Ryu GY, Yoon JG, et al: Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res. 66:6665–6674. 2006. View Article : Google Scholar : PubMed/NCBI
21	Cadieux B, Ching TT, VandenBerg SR and Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res. 66:8469–8476. 2006. View Article : Google Scholar
22	Yu J, Zhang H, Gu J, et al: Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer. 14:652004. View Article : Google Scholar
23	Uhlmann K, Rohde K, Zeller C, et al: Distinct methylation profiles of glioma subtypes. Int J Cancer. 106:52–59. 2003. View Article : Google Scholar : PubMed/NCBI
24	Costello JF, Frühwald MC, Smiraglia DJ, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 24:132–138. 2000. View Article : Google Scholar : PubMed/NCBI
25	Ammerpohl O, Pratschke J, Schafmayer C, et al: Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer. 130:1319–1328. 2012. View Article : Google Scholar : PubMed/NCBI
26	Mayol G, Martín-Subero JI, Ríos J, et al: DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One. 7:e484012012. View Article : Google Scholar
27	Fritz V and Fajas L: Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene. 29:4369–4377. 2010. View Article : Google Scholar : PubMed/NCBI
28	Davis CD, Emenaker NJ and Milner JA: Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer. Semin Oncol. 37:243–257. 2010. View Article : Google Scholar
29	Weinstein IB and Joe A: Oncogene addiction. Cancer Res. 68:3077–3080. 2008. View Article : Google Scholar : PubMed/NCBI
30	McCubrey JA, Steelman LS, Abrams SL, et al: Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul. 46:249–279. 2006. View Article : Google Scholar : PubMed/NCBI
31	Testa JR and Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
32	Protzel C, Knoedel J, Zimmermann U, Woenckhaus C, Poetsch M and Giebel J: Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol. 22:1197–1204. 2007.
33	Yamashita Y, Kasugai I, Sato M, et al: CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples. J Neurooncol. 100:43–49. 2010. View Article : Google Scholar